Literature DB >> 32412405

Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation.

Pierre Miossec1.   

Abstract

Entities:  

Year:  2020        PMID: 32412405      PMCID: PMC7431332          DOI: 10.5152/eurjrheum.2020.2062

Source DB:  PubMed          Journal:  Eur J Rheumatol        ISSN: 2147-9720


× No keyword cloud information.
  13 in total

1.  Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412.

Authors:  Ganesh Suntharalingam; Meghan R Perry; Stephen Ward; Stephen J Brett; Andrew Castello-Cortes; Michael D Brunner; Nicki Panoskaltsis
Journal:  N Engl J Med       Date:  2006-08-14       Impact factor: 91.245

2.  Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12Rbeta2 inhibition.

Authors:  Myew-Ling Toh; Masanori Kawashima; Arnaud Hot; Philippe Miossec; Pierre Miossec
Journal:  Ann Rheum Dis       Date:  2010-06-11       Impact factor: 19.103

3.  COVID-19 and the Heart.

Authors:  Akbarshakh Akhmerov; Eduardo Marbán
Journal:  Circ Res       Date:  2020-04-07       Impact factor: 17.367

4.  Combination of IL-17 and TNFα induces a pro-inflammatory, pro-coagulant and pro-thrombotic phenotype in human endothelial cells.

Authors:  Arnaud Hot; Vanina Lenief; Pierre Miossec
Journal:  Ann Rheum Dis       Date:  2012-01-18       Impact factor: 19.103

5.  Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

Authors:  S A Rosenberg; M T Lotze; L M Muul; S Leitman; A E Chang; S E Ettinghausen; Y L Matory; J M Skibber; E Shiloni; J T Vetto
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

6.  Blockade of Store-Operated Calcium Entry Reduces IL-17/TNF Cytokine-Induced Inflammatory Response in Human Myoblasts.

Authors:  Audrey Beringer; Yves Gouriou; Fabien Lavocat; Michel Ovize; Pierre Miossec
Journal:  Front Immunol       Date:  2019-01-14       Impact factor: 7.561

7.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

8.  Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.

Authors:  Chi Zhang; Zhao Wu; Jia-Wen Li; Hong Zhao; Gui-Qiang Wang
Journal:  Int J Antimicrob Agents       Date:  2020-03-29       Impact factor: 5.283

9.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

10.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

View more
  7 in total

1.  Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro.

Authors:  Santosh V Suryavanshi; Mariia Zaiachuk; Nazar Pryimak; Igor Kovalchuk; Olga Kovalchuk
Journal:  Cells       Date:  2022-04-20       Impact factor: 7.666

Review 2.  COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside.

Authors:  David Sulzer; Angelo Antonini; Valentina Leta; Anna Nordvig; Richard J Smeyne; James E Goldman; Osama Al-Dalahmah; Luigi Zecca; Alessandro Sette; Luigi Bubacco; Olimpia Meucci; Elena Moro; Ashley S Harms; Yaqian Xu; Stanley Fahn; K Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2020-08-20

3.  Treatment of COVID-19 patients with the anti-CD6 antibody itolizumab.

Authors:  Armando Caballero; Lázaro M Filgueira; Julio Betancourt; Naivy Sánchez; Carlos Hidalgo; Alberto Ramírez; Alejandro Martinez; Rolando E Despaigne; Alberto Escalona; Henrry Diaz; Elio Meriño; Lilia M Ortega; Ulises Castillo; Mayra Ramos; Danay Saavedra; Yanelda García; Geydi Lorenzo; Meylán Cepeda; Maylén Arencibia; Leticia Cabrera; Milagros Domecq; Daymys Estévez; Carmen Valenzuela; Patricia Lorenzo; Lizet Sánchez; Zaima Mazorra; Kalet León; Tania Crombet
Journal:  Clin Transl Immunology       Date:  2020-11-25

4.  A Report on Multi-Target Anti-Inflammatory Properties of Phytoconstituents from Monochoria hastata (Family: Pontederiaceae).

Authors:  Md Mazedul Haq; Md Arifur Rahman Chowdhury; Hilal Tayara; Ibrahim Abdelbaky; Md Shariful Islam; Kil To Chong; Sangyun Jeong
Journal:  Molecules       Date:  2021-12-06       Impact factor: 4.411

5.  Low baseline IFN-γ response could predict hospitalization in COVID-19 patients.

Authors:  Marion Cremoni; Jonathan Allouche; Daisy Graça; Kevin Zorzi; Céline Fernandez; Maxime Teisseyre; Sylvia Benzaken; Caroline Ruetsch-Chelli; Vincent L M Esnault; Jean Dellamonica; Michel Carles; Jérôme Barrière; Michel Ticchioni; Vesna Brglez; Barbara Seitz-Polski
Journal:  Front Immunol       Date:  2022-09-26       Impact factor: 8.786

6.  Mediterranean Diet and SARS-COV-2 Infection: Is There Any Association? A Proof-of-Concept Study.

Authors:  Valentina Ponzo; Marianna Pellegrini; Chiara D'Eusebio; Fabio Bioletto; Ilaria Goitre; Silvio Buscemi; Simone Frea; Ezio Ghigo; Simona Bo
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

Review 7.  "Acute Myocardial Infarction in the Time of COVID-19": A Review of Biological, Environmental, and Psychosocial Contributors.

Authors:  Francesca Gorini; Kyriazoula Chatzianagnostou; Annamaria Mazzone; Elisa Bustaffa; Augusto Esposito; Sergio Berti; Fabrizio Bianchi; Cristina Vassalle
Journal:  Int J Environ Res Public Health       Date:  2020-10-09       Impact factor: 3.390

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.